Sohliya, A.E.L. 2025. Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation. International Journal of Research in Medical Sciences. 13, 2 (Jan. 2025), 987–988. DOI:https://doi.org/10.18203/2320-6012.ijrms20250291.